DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Vivo Bio Tech Ltd (VIVOBIOT) share price today?

Vivo Bio Tech Ltd (VIVOBIOT) is trading at ₹23.48 on the BSE, down 0.34% on the day. Source: DocStoX.

What is the PE ratio of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd has a price-to-earnings (PE) ratio of 5.5 in the Healthcare sector.

What is the market capitalisation of Vivo Bio Tech Ltd?

Vivo Bio Tech Ltd has a market capitalisation of approximately ₹52 crore.

Vivo Bio Tech Ltd

VIVOBIOT·BSE·Healthcare

₹23.48▼ -0.08 (-0.34%)

Healthcare · Pharmaceuticals & Biotechnology

A steady, established business

Day₹23.15

₹24.40

52W₹20

₹4314%

Open

₹23.16

High

₹24.40

Low

₹23.15

Prev Close

₹23.56

Volume

8.8K

VWAP

₹23.35

Snapshot

Key fundamentals

Market Cap

₹52 Cr

P/E Ratio

5.54Cheap

P/B Ratio

0.57

EPS

₹4.24

Book Value

₹41.25

ROE

-2.00%Weak

ROCE

9.04%Weak

Dividend Yield

0.00%

Debt / Equity

0.72Moderate

Face Value

₹10.00

52W High

₹43.35

52W Low

₹20.35

Sector

Healthcare

Industry

Pharmaceuticals & Biotechnology

Buy

None moatMedium uncertainty

Fair value estimate

₹40

▲ 70.4%upside

Trading at ₹23 — 70% below our estimate

BearFair valueBull

₹34₹40₹46

/100

Business quality — Watch the fundamentals

Growth 50Profitability 38Efficiency 5Valuation 82

Plain English

Our view

A steady, established business
Reasonably priced at 6× earnings
Weak returns on equity (-2%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

5.5Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

-2.0%Weak

Above 15% is considered healthy for Indian equities

ROCE

9.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.72Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹52 Cr

P/B

0.57

EPS

₹4.24

Div Yield

—

What changed

Recent changes

Promoters+0.27% stake last quarter

What matters

News impact

Overview

Valuation

Attractive

P/E 5.5×

Growth

Slow

+1% rev CAGR

Profitability

Loss-making

-2.0% ROE

Financial health

Comfortable

D/E 0.72

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹2.06L Cr

Trades91

VWAP₹23.35

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+0.7%

+0.6%

10Y

+6.4%

Profit

+14.7%

-6.8%

10Y

+16.0%

EPS

-1.3%

-16.6%

10Y

+5.8%

Profile

Pros

Stock is trading at 0.56 times its book value

Watch-outs

Cons

Company has low interest coverage ratio.
Promoter holding has decreased over last quarter: -4.81%
The company has delivered a poor sales growth of 0.59% over past five years.
Promoter holding is low: 30.6%
Company has a low return on equity of 2.24% over last 3 years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters raised their stake by 0.27 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

35%

Promoter

Promoters

35.4%+0.27

Public

32.4%-0.33

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

32.2%

Total shareholders

21,427-195 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter35.43%

Public32.37%

Others32.20%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]

Vivo Bio Tech Ltd valuation & research

Deep-dive tools with DocStoX's fair-value estimate, ratios and peers.

Fair Value Intrinsic Value DCF Valuation Financial Ratios Peers

Vivo Bio Tech Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Ltd Divis Laboratories Ltd Torrent Pharmaceuticals Ltd Apollo Hospitals Enterprise Ltd Zydus Lifesciences Ltd Cipla Ltd Lupin Ltd Max Healthcare Institute Ltd Mankind Pharma Ltd Dr Reddys Laboratories Ltd Aurobindo Pharma Ltd Laurus Labs Ltd

Compare Vivo Bio Tech Ltd with peers

Vivo Bio Tech Ltd vs Sun Pharmaceutical Industries Ltd Vivo Bio Tech Ltd vs Divis Laboratories Ltd Vivo Bio Tech Ltd vs Torrent Pharmaceuticals Ltd Vivo Bio Tech Ltd vs Apollo Hospitals Enterprise Ltd Vivo Bio Tech Ltd vs Zydus Lifesciences Ltd Vivo Bio Tech Ltd vs Cipla Ltd

Related tools & concepts

Value Vivo Bio Tech Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Vivo Bio Tech Ltd

Key fundamentals

Key statistics

Recent changes

News impact

Overview

Trading activity

Technical signals

Growth (CAGR)

Company information

Pros

Cons

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership breakdown

Ownership over time

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Frequently asked questions

Vivo Bio Tech Ltd valuation & research

Vivo Bio Tech Ltd peers in Healthcare

Compare Vivo Bio Tech Ltd with peers

Related tools & concepts

Key statistics

Recent changes

News impact

Trading activity

Technical signals

Growth (CAGR)

Company information

Pros

Cons

Ownership breakdown

Ownership over time

Frequently asked questions